ASRT
Assertio Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$151.47M
P/E Ratio
—
EPS
$-5.55
Beta
0.45
52W High
$23.46
52W Low
$8.61
50-Day MA
$18.95
200-Day MA
$13.57
Dividend Yield
—
Profit Margin
-34.90%
Forward P/E
769.23
PEG Ratio
1.50
About Assertio Therapeutics Inc
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medications in the areas of neurology, hospital, and pain and inflammation. The company is headquartered in Lake Forest, Illinois.
Fundamentals
| Revenue (TTM) | $102.16M |
| Gross Profit (TTM) | $71.85M |
| EBITDA | $3.83M |
| Operating Margin | -185.90% |
| Return on Equity | -38.80% |
| Return on Assets | -5.71% |
| Revenue/Share (TTM) | $15.92 |
| Book Value | $11.73 |
| Price-to-Book | 2.00 |
| Price-to-Sales (TTM) | 1.48 |
| EV/Revenue | 1.174 |
| EV/EBITDA | 45.69 |
| Quarterly Earnings Growth (YoY) | -18.80% |
| Quarterly Revenue Growth (YoY) | -62.50% |
| Shares Outstanding | $6.46M |
| Float | $5.63M |
| % Insiders | 1.97% |
| % Institutions | 39.94% |
Historical Volatility
HV 10-Day
17.59%
HV 20-Day
56.02%
HV 30-Day
46.50%
HV 60-Day
62.08%
HV Rank
23.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($24.43 target)
1
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026